When looking at individual categories, the sFlt1/PlGF ratio was significantly elevated among all categories of adverse outcomes (except severe HTN) among patients with both early onset and late onset PE (Fig 3A and 3B, Table 2). The gene discussed is PGF; the disease is hypertensive disorder.